This is a complex issue, involving many components. For investment, the gap (yawning chasm) is in the early stage (pre Series A). At Adrenaline, unlike many Canadian funds, we invest ONLY in Canadian startups at the rate of 10 a year. We are doing our part
thelogic.co/news/venture...

Totally agree that a few AI companies are in a bubble many times the Dot Com meltdown. Unlike that time, also strongly believe this has undervalued many other tech theses (incl. AI-driven SaaS) fuelling our conviction that now is perfect for early stage investment
www.saastr.com/the-1-5-tril...

Is this the turning point for VC liquidity? More IPOs, interest rates continuing down, and more. All drive follow on rounds and M&A for early stage companies.
pitchbook.com/news/article...

Looking forward to an important discu0ssion at #NACOSummit moderated by @randallh.bsky.social our General Partner
www.linkedin.com/posts/randal...

This is a huge win for our portfolio company Eleven-x as it transforms the parking landscape
#ClimateTech
eleven-x.com/company/news...

CSE public company Treatment.com AI Inc (CSE:TRUE, Frankfurt: TREIF) has signed an agreement to acquire our portfolio company @rocketdoctor.bsky.social
The combination means that two clinician-led digital health solution providers are joining forces.
www.globenewswire.com/news-release...

BREAKING. Our portfolio company VoxCell BioInnovation won LEAP Landing Award at the major global event in Saudi Arabia. Congratulations to founder, CEO Karolina Valente and the entire team. And for sure the US$150,000 non-dilutive prize will further help you deliver on this huge opportunity.

Canadians powering a diversified and dynamic economy by investing in Canadian startups.

Go #TeamCanada

We were pleased that our general partners, @randallh.bsky.social and Benton Leong were able to share wisdom about best practices in angel investment at a recent Brampton Angels panel. The summary provides should help others learn and grow angel capacity.
www.linkedin.com/posts/brampt...

Great article in Waterloo Region Record covering GTAN with a shout out to how we work with the Angel ecosystem

HDAX Therapeutics is a company on the move recently added to our portfolio. Amazing to support co-founders Nabanita Nawar, Pimyupa Manaswiyoungkul and their team as they pioneer next gen precision therapeutics targeting cardiovascular disease and neuropathies.
www.linkedin.com/posts/hdaxtx...

Canadians have often been seen as being highly risk averse - and it's often cited as a barrier to investment and future productivity. Not so in the world of startups, where Canadian founders aspire to bend the universe with world beating confidence.[Paywall]
1 /4
www.economist.com/business/202...

Kia stands by its 1.6 million EV sales goal with new affordable models driving demand

Will Rivian be Volkswagen’s software savior? VW is betting $5.8B it will